4//SEC Filing
de Notaristefani Carlo 4
Accession 0001209191-18-009181
CIK 0000818686other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:17 PM ET
Size
8.3 KB
Accession
0001209191-18-009181
Insider Transaction Report
Form 4
de Notaristefani Carlo
Executive VP Global Operations
Transactions
- Award
Stock Options (right to buy)
2018-02-09+159,819→ 159,819 totalExercise: $18.61Exp: 2028-02-08→ Ordinary Shares (159,819 underlying) - Award
Restricted Share Units
2018-02-09+62,690→ 62,690 total→ Ordinary Shares (62,690 underlying)
Footnotes (4)
- [F1]Stock options were granted on February 9, 2018, with 53,273 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F3]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F4]Restricted share units were granted on February 9, 2018, with 20,896 vesting on each of February 9, 2020 and February 9, 2021 and 20,898 vesting on February 9, 2022.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001719114
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:17 PM ET
- Size
- 8.3 KB